Skip to main content
Log in

Regression of left ventricular hypertrophy by acebutolol and nifedipine

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Fourteen patients with previously untreated essential hypertension and left ventricular hypertrophy were treated with a fixed-dose combination of acebutolol 200 mg and nifedipine 20 mg once daily for a followup of 25.6±1.8 months. Echocardiography showed a significant decrease after a mean period of 6.6 months in interventricular septal thickness (14.8%, p<0.001), posterlor wall thickness (14.8%, p<0.001), and left ventricular mass index (21.3%). After 25.6 months, the reductions were 29% (p<0.001), 28.1% (p<0.001), and 38.7% (p<0.001), respectively. Left wall thickness was significantly reduced, but left ventricular end-systolic and end-diastolic dimensions and fractional shortening remained unchanged. Treatment reduced resting blood pressure from 161/102 mmHg to 132/87 mmHg (p<0.001) and reduced exercise blood pressure at 100 W from 208/113 mmHg to 170/94 mmHg (p<0.001). Thus, nifedipine in combination with acebutolol produces significant blood-pressure reduction accompanied by regression of left ventricular hypertrophy without noticeable changes in left ventricular function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977;55:613–618.

    Google Scholar 

  2. Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Am J Cardiol 1982;49:795–801.

    Google Scholar 

  3. Corea L, Bentivoglio M, Verdecchia P, Provvidenza M, Motolese M. Regression of left ventricular hypertrophy during metoprolol treatment. Int J Clin Pharmacol 1984; 22:365–370.

    Google Scholar 

  4. Franz I-W, Wiewel D, Behr U, Ketelhut R. Regression of myocardial hypertrophy in hypertensives on long-term treatment with beta-blockers. Dtsch Med Wochenschr 1986; 111:530–534.

    Google Scholar 

  5. Kaul M, Mohan JC, Bhatia M. Effects of labetalol on left ventricular mass and function in hypertension: An assessment by serial echocardiography. Int J Cardiol 1984;5:461–469.

    Google Scholar 

  6. Drayer JIM, Gardin JM, Weber MA, Aranow WS. Increases and decreases in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 1982;32:283.

    Google Scholar 

  7. Sen S, Tarazi RC, Khairallah PA, Bumpus FMM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974;35:775–781.

    Google Scholar 

  8. Nakashima J, Fouad F, Tarazi R. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984;53:1044–1049.

    Google Scholar 

  9. Strauer BB, Mahmoud M, Bayer F, Bohn J, Motz M. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J 1984; 5(Suppl 7):53–60.

    Google Scholar 

  10. Franz I-W, Tönnesman U, Behr U, Ketelhut R. Long-term effect of antihypertensive therapy on left ventricular hypertrophy. J Hyperten 1987;5(Suppl 5): S415-S418.

    Google Scholar 

  11. Sahn DJ, de Maria A, Kisslo J, Weymann A. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1977;58: 1072–1083.

    Google Scholar 

  12. Franz I-W. Ergometry in hypertensive patients. Berlin: Springer, 1985.

    Google Scholar 

  13. Ren J, Hakki A, Kotler MN. Exercise systolic blood pressure: A powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol 1985;5:1224–1231.

    Google Scholar 

  14. Nathwani D, Reevers RA, Marquez-Julio A. Left ventricular hypertrophy in mild hypertension: Correlation with exercise blood pressure. Am Heart J 1985;109:386–387.

    Google Scholar 

  15. Devereux RB, Pickering TG, Harshfield GA. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure to regularly recurring stress. Circulation 1983;68:470–476.

    Google Scholar 

  16. Franz I-W. Differential antihypertensive effect of acebutolol and the fixed combination hydrochlorothiazide/amiloride hydrochloride on elevated exercise blood pressure in hypertensive patients. Am J Cardiol 1980;46:301–305.

    Google Scholar 

  17. Franz I-W, Wiewel D. Antihypertensive effects of calcium antagonists, β-receptor blockers and their combination on blood pressures at rest and during exercise in hypertensive patients. J Cardiovasc Pharmacol 1985;6(Suppl 7):1037–1042.

    Google Scholar 

  18. Franz I-W. The effects of prazosin and acebutolol and their combination on blood pressure and pressure rate product during ergometric work in hypertensive patients. Z Kardiol 1983;72:746–754.

    Google Scholar 

  19. Franz I-W, Behr U, Ketelhut R. Resting and exercise blood pressure with atenolol, enalapril and a low-dose combination. J Hyperten 1987;5(Suppl 3):S37-S41.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franz, IW., Tönnesmann, U., Behr, U. et al. Regression of left ventricular hypertrophy by acebutolol and nifedipine. Cardiovasc Drug Ther 3 (Suppl 1), 313–317 (1989). https://doi.org/10.1007/BF00148476

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00148476

Key Words

Navigation